China Renaissance Capital Investment (China)
Dr. Karen Liu has worked in China for over 12 years; Her past experiences include management consulting at McKinsey & Company and a successful entrepreneurship helping to build up one of the leading Internet company in China and eventually sold the company to Yahoo; Dr. Liu had also been an active angel investor in the biotechnology sector. She is a founder and angel investor for Shenogen Pharma Group, a new drug development venture with a promising pipeline of anti-cancer drugs. Dr. Liu is currently an investment director at CRCI Capital, a premier China based VC and PE investment firm. She focuses on investing in the life science and biomedical sector and her past investment experience include sectors such as medical device, drug development, industrial biotech, specialty pharma, CRO as well as pharmaceutical fine chemical.
Dr. Liu has a PhD in Immunology from Harvard University and BS in Biochemistry from Cornell University.